Skip to main content
Click Here For COVID-19 Studies
Home
Clinical Trials Office Register as a Researcher Log In
354 Studies Now Enrolling
 Menu
Home How It Works Resources Join RecruitMe

Search

Reset

Status

  • Closed (3)

Medical Condition

  • Show all (187)
  • Autoimmune Disorders (3)
  • Blood Disorders (9)
    • Amyloidosis (2)
    • (-) Sickle Cell Disease (2)
  • Cancer (113)
    • Bladder Cancer (1)
    • Brain Cancer (2)
    • Breast Cancer (2)
    • Gastrointestinal (3)
    • Gynecologic Cancer (4)
    • Head and Neck Cancer (2)
    • Kidney Cancer (3)
    • Leukemia (10)
    • (-) Liver Cancer (1)
    • Lung Cancer (14)
    • Lymphoma (8)
    • Multiple Myeloma (6)
    • Pancreatic Cancer (1)
    • Prostate Cancer (9)
    • Sarcoma (4)
    • Skin Cancer (5)
    • Solid Tumors (7)
  • Diabetes (1)
  • Healthy Volunteers (4)
  • Heart Disease (2)
  • Infectious Disease (3)
  • Neurological Disorders (17)
  • Nutrition (1)
  • Obstetrics & Gynecology (1)
  • Pediatrics (15)
  • Psychiatric Disorders (1)
  • Transplant (16)
  • Urology (1)
Displaying 1 - 3 of 3

Study of stem cell transplant effects in patients with sickle cell disease

Condition: Blood Disorders / Sickle Cell Disease
Investigator: Monica Bhatia, MD
Status: Closed
This study is being done to see if giving your child a lower dose of chemotherapy (drug therapy), than has been used historically in bone marrow transplant, to kill his/her own diseased cells before he/she receives a bone marrow transplant, will possibly result in the permanent control of your child's sickle…
Read More

Study of EDIT-301 in Patients with Severe Sickle Cell Disease (SCD)

Condition: Blood Disorders / Sickle Cell Disease
Investigator: Monica Bhatia, MD
Status: Closed
The purpose of this study is to find out if the study medicine called EDIT-301 will help in the treatment of Severe Sickle Cell Disease (SCD) and how safe it is to be used in people. EDIT-301 (study medicine) is a new investigational therapy which uses the patient's own stem…
Read More

A Study of Atezolizumab Plus Bevacizumab Therapy in Patients With Hepatocellular Carcinoma at High Risk of Recurrence

Condition: Cancer / Liver Cancer
Investigator: Gulam Manji, MD, PhD
Status: Closed
The purpose of this study is to compare the effects, good or bad, of atezolizumab plus bevacizumab versus observation (not receiving any treatment) on patients with completely resected (surgically removed) or ablated (removed using heat) hepatocellular carcinoma (the most common type of liver cancer) who are at high risk for…
Read More
This website uses cookies as well as similar tools and technologies to understand visitors’ experiences. By continuing to use this website, you consent to Columbia University’s usage of cookies and similar technologies, in accordance with the Columbia University Website Cookie Notice.
I AGREE
COMPLIANCE
Compliance Hotline Compliance Program
RESOURCES
Contact RecruitMe Terms of Use Privacy Policy ©2025 Columbia University
SCHOOLS
Vagelos College of Physicians and Surgeons Mailman School of Public Health School of Nursing College of Dental Medicine Graduate School of Arts and Science